Brinter was thrilled to meet people in person and create new contacts at the Biocity Symposium with the title CANCER – BREAKING BAD in Turku last week. Finally, a partly physical and partly virtual scientific meeting could be arranged despite the COVID-19 situation and allowed us to demonstrate Brinter® 3D bioprinting platform in action! As you are aware, cancer research is one of Brinter’s core application areas.

The annual BioCity Symposium was arranged for the 30th time. This series of meetings organized since 1991 has become the most important yearly get-together in the fields of biosciences and molecular medicine in Turku.

BioCity Turku is a community of life science and molecular medicine researchers and students in the Turku region. One of its main events is the yearly BioCity Symposium. This year the event was organized in collaboration with Finnish Cancer Institute as a hybrid event with some of the audience and invited speakers present in Turku and virtual participants following the broadcasted program.

The Symposium had an impressive list of invited speakers. This year’s program consisted of nine talks from international scientists spiced up with short talks from Finnish researchers.

www.brinter.com